RADHA VENKATARAMANAN: Open Payments
NPI 1740620145 · HILLSDALE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$795 in 45 payments from 15 companies in 2025. Trend: 2023 $17 · 2024 $371 · 2025 $795
Food & beverage: $795
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $103 |
| Amgen Inc. | 6 | $98 |
| AstraZeneca Pharmaceuticals LP | 6 | $93 |
| Dexcom, Inc. | 5 | $89 |
| Kowa Pharmaceuticals America, Inc. | 5 | $74 |
| ABBVIE INC. | 4 | $70 |
| Lilly USA, LLC | 3 | $54 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $52 |
| PFIZER INC. | 2 | $35 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35 |
Products named: Dexcom G6 Transmitter, ZORYVE, JARDIANCE, Ozempic, OTEZLA, Kerendia, FARXIGA, BREZTRI.
Industry payments across NJ — which companies pay providers there.
